Prostate brachytherapy and second primary cancer risk: A competitive risk analysis

Journal of Clinical Oncology

Volumn 29, Issue 34, 2011, Pages 4510-4515

  Hinnen, Karel A ^a   Schaapveld, Michael ^a   Van Vulpen, Marco ^b   Battermann, Jan J ^b   Van Der Poel, Henk ^a   Van Oort, Inge M ^c   Van Roermund, Joep G H ^d   Monninkhof, Evelyn M ^b  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CATHARINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125;

ADULT; AGED; ANUS CANCER; ARTICLE; BLADDER CANCER; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SURGERY; COMPARATIVE STUDY; FOLLOW UP; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SECOND CANCER; SKIN CANCER; THERAPY EFFECT; URINARY TRACT CANCER;

AGED; BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SEER PROGRAM;

EID: 83255164854     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.35.0991     Document Type: Article

References (40)

1. Kupelian PA, Potters L, Khuntia D, et al.: Radical prostatectomy, external beam radiotherapy < 72Gy, external beam radiotherapy ≥ 72Gy, permanent seed implantation, or combined seeds/ external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 58:25-33, 2004 (Pubitemid 38010333)
2. Hinnen KA, Battermann JJ, van Roermund JG, et al.: Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 76:1433-1438, 2009
3. Sylvester JE, Grimm PD, Wong J, et al.: Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience. Int J Radiat Oncol Biol Phys 81: 376-381, 2011
4. Henry AM, Al-Qaisieh B, Gould K, et al.: Outcomes following iodine-125 monotherapy for localized prostate cancer: The results of leeds 10-year single-center brachytherapy experience. Int J Radiat Oncol Biol Phys 76:50-56, 2010
5. Henderson A, Laing RW, Langley SE: Quality of life following treatment for early prostate cancer: Does low dose rate (LDR) brachytherapy offer a better outcome? A review. Eur Urol 45:134-141, 2004 (Pubitemid 38147817)
6. Malcolm JB, Fabrizio MD, Barone BB, et al.: Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer. J Urol 183:1822-1828, 2010
7. Müller AC, Ganswindt U, Bamberg M, et al.: Risk of second malignancies after prostate irradiation? Strahlenther Onkol 183:605-609, 2007 (Pubitemid 350124275)
8. Bostrom PJ, Soloway MS: Secondary cancer after radiotherapy for prostate cancer: Should we be more aware of the risk? Eur Urol 52:973- 982, 2007
9. Schouten LJ, Straatman H, Kiemeney LA, et al.: The capture-recapture method for estimation of cancer registry completeness: A useful tool? Int J Epidemiol 23:1111-1116, 1994
10. Schouten LJ, Hoppener P, van den Brandt PA, et al.: Completeness of cancer registration in limburg, the netherlands. Int J Epidemiol 22:369-376, 1993 (Pubitemid 23208931)
11. Nag S, Bice W, DeWyngaert K, et al.: The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys 46:221-230, 2000 (Pubitemid 30021503)
12. Moerland MA, van Deursen MJ, Elias SG, et al.: Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: Comparison between loose and stranded seed implants. Radiother Oncol 91:202-206, 2009
13. Breslow NE, Day NE: Statistical methods in cancer research: Volume II - The design and analysis of cohort studies. IARC Sci Publ 82:1-406, 1987
14. Boshuizen HC, Feskens EJ: Fitting additive Poisson models. Epidemiol Perspect Innov 7:4, 2010
15. Fine JP, Gray RJ: A proportional hazards model for subdistribution of a competing risk. J Am Stat Assoc 94:496-509, 1999
16. Preston DL, Ron E, Tokuoka S, et al.: Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 168:1-64, 2007 (Pubitemid 351292925)
17. Pierce DA, Preston DL: Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat Res 154:178-186, 2000 (Pubitemid 30612918)
18. Cardis E, Howe G, Ron E, et al.: Cancer consequences of the chernobyl accident: 20 years on. J Radiol Prot 26:127-140, 2006 (Pubitemid 43861071)
19. Xu XG, Bednarz B, Paganetti H: A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction. Phys Med Biol 53:R193-R241, 2008 (Pubitemid 352020053)
20. Suit H, Goldberg S, Niemierko A, et al.: Secondary carcinogenesis in patients treated with radiation: A review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat Res 167:12-42, 2007 (Pubitemid 46106795)
21. Shirodkar SP, Kishore TA, Soloway MS: The risk and prophylactic management of bladder cancer after various forms of radiotherapy. Curr Opin Urol 19:500-503, 2009
22. Neugut AI, Ahsan H, Robinson E, et al.: Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma. Cancer 79: 1600-1604, 1997 (Pubitemid 27154794)
23. Brenner DJ, Curtis RE, Hall EJ, et al.: Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 88: 398-406, 2000 (Pubitemid 30051826)
24. Moon K, Stukenborg GJ, Keim J, et al.: Cancer incidence after localized therapy for prostate cancer. Cancer 107:991-998, 2006 (Pubitemid 44291148)
25. Nieder AM, Porter MP, Soloway MS: Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: A population based cohort study. J Urol 180:2005-2009, 2008
26. Singh AK, Mashtare TL, McCloskey SA, et al.: Increasing age and treatment modality are predictors for subsequent diagnosis of bladder cancer following prostate cancer diagnosis. Int J Radiat Oncol Biol Phys 78:1086-1094, 2010
27. Chrouser K, Leibovich B, Bergstralh E, et al.: Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. J Urol 174:107-110, 2005 (Pubitemid 40825684)
28. Pickles T, Phillips N: The risk of second malignancy in men with prostate cancer treated with or without radiation in british columbia, 1984-2000. Radiother Oncol 65:145-151, 2002 (Pubitemid 35441045)
29. Bhojani N, Capitanio U, Suardi N, et al.: The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: A population-based study on 17,845 patients. Int J Radiat Oncol Biol Phys 76:342-348, 2010
30. Boorjian S, Cowan JE, Konety BR, et al.: Bladder cancer incidence and risk factors in men with prostate cancer: Results from cancer of the prostate strategic urologic research endeavor. J Urol 177:883-887, 2007
31. Baxter NN, Tepper JE, Durham SB, et al.: Increased risk of rectal cancer after prostate radiation: A population-based study. Gastroenterology 128:819-824, 2005 (Pubitemid 40523534)
32. Kendal WS, Eapen L, Macrae R, et al.: Prostatic irradiation is not associated with any measurable increase in the risk of subsequent rectal cancer. Int J Radiat Oncol Biol Phys 65:661-668, 2006 (Pubitemid 43795833)
33. Rapiti E, Fioretta G, Verkooijen HM, et al.: Increased risk of colon cancer after external radiation therapy for prostate cancer. Int J Cancer 123: 1141-1145, 2008
34. Holm HH: The history of interstitial brachytherapy of prostatic cancer. Semin Surg Oncol 13: 431-437, 1997
35. Tubiana M: Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol 91:4-15, 2009
36. Pira E, Piolatto G, Negri E, et al.: Bladder cancer mortality of workers exposed to aromatic amines: A 58-year follow-up. J Natl Cancer Inst 102:1096-1099, 2010
37. Brawley OW, Jani AB, Master V: Prostate cancer and race. Curr Probl Cancer 31:211-225, 2007 (Pubitemid 46830809)
38. Huang J, Kestin LL, Ye H, et al.: Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer. Radiother Oncol 98:81-86, 2011
39. Liauw SL, Sylvester JE, Morris CG, et al.: Second malignancies after prostate brachytherapy: Incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. Int J Radiat Oncol Biol Phys 66:669-673, 2006 (Pubitemid 44436687)
40. Abdel-Wahab M, Reis IM, Hamilton K: Second primary cancer after radiotherapy for prostate cancer-a seer analysis of brachytherapy versus external beam radiotherapy. Int J Radiat Oncol Biol Phys 72:58-68, 2008